HLN
Price
$8.97
Change
+$0.13 (+1.47%)
Updated
Sep 30 closing price
Capitalization
39.48B
29 days until earnings call
LIFD
Price
$0.29
Change
-$0.00 (-0.00%)
Updated
Sep 30 closing price
Capitalization
4.3M
Interact to see
Advertisement

HLN vs LIFD

Header iconHLN vs LIFD Comparison
Open Charts HLN vs LIFDBanner chart's image
Haleon
Price$8.97
Change+$0.13 (+1.47%)
Volume$11.23M
Capitalization39.48B
LFTD Partners
Price$0.29
Change-$0.00 (-0.00%)
Volume$600
Capitalization4.3M
HLN vs LIFD Comparison Chart in %
Loading...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIFD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLN vs. LIFD commentary
Oct 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a StrongBuy and LIFD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 01, 2025
Stock price -- (HLN: $8.84 vs. LIFD: $0.29)
Brand notoriety: HLN and LIFD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLN: 96% vs. LIFD: 6%
Market capitalization -- HLN: $39.48B vs. LIFD: $4.3M
HLN [@Pharmaceuticals: Generic] is valued at $39.48B. LIFD’s [@Pharmaceuticals: Generic] market capitalization is $4.3M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $64.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 1 FA rating(s) are green whileLIFD’s FA Score has 1 green FA rating(s).

  • HLN’s FA Score: 1 green, 4 red.
  • LIFD’s FA Score: 1 green, 4 red.
According to our system of comparison, LIFD is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 5 TA indicator(s) are bullish while LIFD’s TA Score has 4 bullish TA indicator(s).

  • HLN’s TA Score: 5 bullish, 6 bearish.
  • LIFD’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, LIFD is a better buy in the short-term than HLN.

Price Growth

HLN (@Pharmaceuticals: Generic) experienced а -1.78% price change this week, while LIFD (@Pharmaceuticals: Generic) price change was +3.61% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.69%. For the same industry, the average monthly price growth was +45.06%, and the average quarterly price growth was +96.58%.

Reported Earning Dates

HLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.69% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($39.5B) has a higher market cap than LIFD($4.3M). HLN has higher P/E ratio than LIFD: HLN (20.03) vs LIFD (13.93). HLN YTD gains are higher at: -5.708 vs. LIFD (-40.816). HLN has higher annual earnings (EBITDA): 2.71B vs. LIFD (-11.91K). HLN has more cash in the bank: 676M vs. LIFD (2.12M). LIFD has less debt than HLN: LIFD (4.38M) vs HLN (8.45B). HLN has higher revenues than LIFD: HLN (11B) vs LIFD (36.6M).
HLNLIFDHLN / LIFD
Capitalization39.5B4.3M918,818%
EBITDA2.71B-11.91K-22,777,265%
Gain YTD-5.708-40.81614%
P/E Ratio20.0313.93144%
Revenue11B36.6M30,055%
Total Cash676M2.12M31,947%
Total Debt8.45B4.38M192,882%
FUNDAMENTALS RATINGS
LIFD: Fundamental Ratings
LIFD
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
32
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLNLIFD
RSI
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
40%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 2 days ago
55%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
52%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIFD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCPL2.380.14
+6.25%
NETCAPITAL INC.
TBBB26.790.53
+2.02%
BBB Foods
CMS72.770.93
+1.29%
CMS Energy Corp
MGTX8.250.07
+0.86%
MeiraGTx Holdings plc
RBKB11.44-0.40
-3.38%
Rhinebeck Bancorp

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
+0.23%
HLNCF - HLN
49%
Loosely correlated
+2.78%
TAK - HLN
42%
Loosely correlated
-0.81%
ZTS - HLN
38%
Loosely correlated
-0.31%
PRGO - HLN
30%
Poorly correlated
+1.31%
ALKS - HLN
28%
Poorly correlated
+4.12%
More

LIFD and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIFD has been loosely correlated with LVZPF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if LIFD jumps, then LVZPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIFD
1D Price
Change %
LIFD100%
N/A
LVZPF - LIFD
34%
Loosely correlated
N/A
CRRTF - LIFD
29%
Poorly correlated
N/A
BFRI - LIFD
6%
Poorly correlated
+0.83%
HLN - LIFD
5%
Poorly correlated
+0.23%
SHPH - LIFD
3%
Poorly correlated
-5.24%
More